KRAS Antibody

The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.

KRAS is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma.This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Mouse.

We have publications tested in 1 application: WB.

Showing Publication 1 - 1 of 1.

Publication using NBP1-58261	Applications	Species
Kapil S, Sharma BK, Patil M et al. The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. Oncotarget 2017-04-18 [PMID: 28460446] (WB, Mouse) Details: This KRAS antibody was used to examine differences in expression of KRAS in control cells vs Scrib-OE Huh-7 cells	WB	Mouse

Array NBP1-58261

• KRAS Antibodies
• KRAS ELISA Kits
• KRAS Lysate
• KRAS Proteins